Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 15.1660.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 15.16 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202515.16
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 15.16
-75.04
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹25,254.8 Cr 0.2% -11.5% 2.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.2%

-11.5%

2.9%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses